Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), a self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on organ fibrosis, today announced financial results ...
Zacks Investment Research on MSN8h
Strength Seen in BioHarvest Sciences Inc. (BHST): Can Its 12.7% Jump Turn into More Strength?BioHarvest Sciences Inc. (BHST) shares ended the last trading session 12.7% higher at $5.85. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...
Volcon Inc. (NASDAQ:VLCN) (”Volcon’’, the “Company” or “we”), the first all-electric, off-road powersports company, today reported its operational highlights and financial results for the ...
According to the Farm Bureau, US egg prices in 2025 have surged over 350% compared to last year, driven by inflation and a ...
The number of single-use handpiece units shipped in Q4 2024 exceeded expectations, increasing 5% overall and 20% in the U.S. compared to the same ...
Discover how the combination of honey and cinnamon can support weight management, oral health, digestion, energy levels, ...
Mardi Gras gives people the opportunity to celebrate before the Lenten season, where people become more disciplined and give ...
Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”) today reported fiscal fourth quarter and full fiscal year 2024 financial results for the fiscal year ended ...
Feb. 27, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and full year ... compound's ...
During an appearance on the “Games With Names” podcast, Ridley recalled the ex-Patriots coach putting him in “fat camp” because ... his hiring, Dec. 12, 2024, in Chapel Hill, N.C ...
"Once again, we had a record number of new Korlym ® prescribers and a record number of patients receiving Korlym in the quarter. Physicians are increasingly aware of hypercortisolism’s true ...
--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for the fourth quarter and year-end 2024 and provided ... intrahepatic cholestasis (PFIC) patients 12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback